<DOC>
	<DOCNO>NCT01513070</DOCNO>
	<brief_summary>This study investigate effective power angina pectoris Quick-Acting Heart Reliever isosorbide dinitrate interventing respectively patient moderate coronary stenosis six month . At time , study ass plaque , myocardial blood-supplying , quality life observe end point heart ( include myocardial revascularization , death myocardial infarction ) . The purpose study function blood-quickening stasis-transforming formula Quick-Acting Heart Reliever moderate coronary stenosis lesion .</brief_summary>
	<brief_title>A Clinical Trials Quick-Acting Heart Reliever Moderate Coronary Stenosis</brief_title>
	<detailed_description>Blood-quickening stasis-transforming medicinal Chinese medicinal ameliorate clinical symptom coronary artery disease . Quick-Acting Heart Reliever one blood-quickening stasis-transforming medicinals relieve angina pectoris clinic especially benefit patient moderate coronary stenosis need coronary revascularization medical treatment . But randomize evidence establish beneficial effect blood-quickening stasis-transforming medicinals treat moderate coronary stenosis lesion . This study randomize double-blind placebo-controlled clinical trial . A total 120 consecutive participant least one moderate coronary stenosis lesion ( diameter stenosis 50-75 % ) randomize two group : group 1 ( n =60 ) receive Quick-Acting Heart placebo isosorbide dinitrate , patient group 2 ( n = 60 ) receive isosorbide dinitrate placebo Quick-Acting Heart six month . The myocardial perfusion image coronary CT angiography use evaluate effective power angina pectoris , myocardial blood-supplying，the quality volume plaque , diameter stenosis treat 6 month end point heart ( include death，myocardial infarction myocardial revascularization include intracoronary stenting coronary artery bypass grafting , ) 12 month . The purpose study function Quick-Acting Heart Reliever delay percutaneous coronary intervention ( PCI ) moderate coronary stenosis .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<criteria>Male female subject 3075 year age Angina CAD patient Diameter stenosis 5075 % least one main coronary artery ( Confirmed coronary arteriography coronary CT angiography ) Not receive percutaneous coronary intervention ( PCI ) Heart blood stasis obstruction syndrome accord TCM syndrome differentiation Provide write informed consent . Heart transplant history CABG history percutaneous transluminal coronary angioplasty ( PTCA ) drugeluting stent . Left ventricular ejection fraction &lt; 35 % Acute myocardial infarction within 4 week prior inclusion The contractive pressure &gt; 160 mmHg diastolic pressure &gt; 100 mmHg Severe valvular heart disease Insulindependent diabetes mellitus Serious heart , lung , liver , kidney brain primary complication Mental patient Diagnosed suspected tumor Allergic person Pregnant , breastfeeding , intend become pregnant course study ( female ) Patients willing able give inform consent participate study The patient attend clinical trial The person maybe loss reason work life condition accord investigator 's judgement</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Quick-Acting Heart Reliever</keyword>
	<keyword>Coronary Artery Stenosis</keyword>
	<keyword>Coronary Heart Disease</keyword>
	<keyword>Suxiao Jiuxin Pill</keyword>
	<keyword>Chinese Herbal Drugs</keyword>
	<keyword>Traditional Chinese Medicine</keyword>
	<keyword>Chinese Medicine</keyword>
	<keyword>Angina Pectoris</keyword>
	<keyword>Isosorbide Dinitrate</keyword>
	<keyword>Myocardial Perfusion Imaging</keyword>
	<keyword>Clinical Trial</keyword>
</DOC>